XML 62 R42.htm IDEA: XBRL DOCUMENT v3.6.0.2
Goodwill and Other Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in Carrying Amount of Goodwill
 
Balance as of December 31, 2016
Goodwill
Adjustments
and
Acquisitions
Balance as of December 31, 2015
Goodwill
Adjustments
and
Acquisitions
Balance as of December 31, 2014
Agriculture
$
343

$
7

$
336

$
18

$
318

Electronics & Communications
149


149


149

Industrial Biosciences
1,175

(34
)
1,209

(9
)
1,218

Nutrition & Health
2,053

(39
)
2,092

(101
)
2,193

Performance Materials
381

(2
)
383

8

375

Protection Solutions
34


34


34

Other
45


45


45

Total
$
4,180

$
(68
)
$
4,248

$
(84
)
$
4,332

Schedule of Other Intangible Assets
 
December 31, 2016
December 31, 2015
 
Gross
Accumulated
Amortization
Net
Gross
Accumulated
Amortization
Net
Intangible assets subject to amortization
     (Definite-lived)
 
 
 
 
 
 
Customer lists
$
1,574

$
(586
)
$
988

$
1,621

$
(529
)
$
1,092

Patents
446

(259
)
187

454

(220
)
234

Purchased and licensed technology
964

(579
)
385

1,173

(649
)
524

Trademarks/tradenames1
53

(15
)
38

26

(13
)
13

Other2
171

(82
)
89

180

(72
)
108

 
3,208

(1,521
)
1,687

3,454

(1,483
)
1,971

Intangible assets not subject to amortization
     (Indefinite-lived)
 
 
 
 
 
 
In-process research and development
73


73

72


72

Microbial cell factories3
306


306

306


306

Pioneer germplasm4
1,053


1,053

1,048


1,048

Trademarks/tradenames1
545


545

747


747

 
1,977


1,977

2,173


2,173

Total
$
5,185

$
(1,521
)
$
3,664

$
5,627

$
(1,483
)
$
4,144


1. 
The decrease in indefinite-lived intangible trademarks / trade names is the result of a $158 impairment charge recorded during the year ended December 31, 2016 associated with certain acquired trade names. The remaining net book value of the trade names are reflected in definite-lived trademarks / trade names at December 31, 2016. See Note 4 for additional information.
2. 
Primarily consists of sales and grower networks, marketing and manufacturing alliances and noncompetition agreements.
3. 
Microbial cell factories, derived from natural microbes, are used to sustainably produce enzymes, peptides and chemicals using natural metabolic processes. The company recognized the microbial cell factories as an intangible asset upon the acquisition of Danisco. This intangible asset is expected to contribute to cash flows beyond the foreseeable future and there are no legal, regulatory, contractual, or other factors which limit its useful life.
4. 
Pioneer germplasm is the pool of genetic source material and body of knowledge gained from the development and delivery stage of plant breeding. The company recognized germplasm as an intangible asset upon the acquisition of Pioneer. This intangible asset is expected to contribute to cash flows beyond the foreseeable future and there are no legal, regulatory, contractual, or other factors which limit its useful life.